Vitamin B12 combined with methylene blue alleviates experimental septic shock and is associated with modulation of KCNMB1 and the cGMP-PRKG pathway
PLOS One · 06.08.2026 · 21 (8) · e0355117
DOI: 10.1371/journal.pone.0355117 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 06.08.2026. Verfasst von Keji Shan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Shock, Septic, Methylene Blue, Cyclic GMP, Vitamin B 12. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the “Xingdian” Talent Support Program of Yunnan Province—Special Project for Famous Doctors.
Themen: Sepsis
Abstract (Originalsprache)
Background
Septic shock is characterized by severe circulatory failure, microvascular dysfunction, and metabolic derangement. Methylene blue (MB) and vitamin B12 (VB12) have each shown potential benefit in vasodilatory shock, but the biological effects of their combined use remain unclear.
Methods
A rat model of LPS-induced septic shock was used to evaluate the effects of combined MB and VB12 pretreatment. Transcriptomic analysis of carotid artery tissue was performed to identify treatment-responsive genes and pathways. Expression of KCNMB1, PRKG1, and PRKG2 was assessed by immunohistochemistry, western blotting, and RT-qPCR. Hemodynamic parameters, circulating injury markers, inflammatory cytokines, oxidative stress indices, and histological changes in major organs were also evaluated.
Results
Combined MB and VB12 treatment was associated with lower expression of KCNMB1, PRKG1, and PRKG2 and reduced cGMP levels compared with the model group. The combined treatment also partially improved hemodynamic abnormalities, reduced NO, H2S, and lactate levels, and attenuated inflammatory and oxidative stress responses. Histological injury in the lung, liver, kidney, and carotid artery was also alleviated.
Conclusion
In this experimental model, combined MB and VB12 pretreatment attenuated multiple features of septic shock and was accompanied by modulation of KCNMB1 and cGMP-PRKG pathway-related markers. These findings support a potential protective role of the combined regimen, although the causal mechanistic relationship requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
ORCID-Profile: Keji Shan
Förderung
- the “Xingdian” Talent Support Program of Yunnan Province—Special Project for Famous Doctors
Zitieren
APA
Shan, K., Zhao, J., Tang, K., Lei, Y., & Mao, F. (2026). Vitamin B12 combined with methylene blue alleviates experimental septic shock and is associated with modulation of KCNMB1 and the cGMP-PRKG pathway. PLOS One, 21(8), e0355117. https://doi.org/10.1371/journal.pone.0355117
Vancouver
Shan K, Zhao J, Tang K, Lei Y, Mao F. Vitamin B12 combined with methylene blue alleviates experimental septic shock and is associated with modulation of KCNMB1 and the cGMP-PRKG pathway. PLOS One. 2026;21(8):e0355117. doi:10.1371/journal.pone.0355117
BibTeX
@article{Shan2026,
author = {Shan, Keji and Zhao, Jinling and Tang, Kun and Lei, Yuying and Mao, Fukang},
title = {Vitamin B12 combined with methylene blue alleviates experimental septic shock and is associated with modulation of KCNMB1 and the cGMP-PRKG pathway},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {8},
pages = {e0355117},
doi = {10.1371/journal.pone.0355117}
}
EUVIMED